Research Article
Prevalence of Orthostatic Hypertension in Elderly Patients with Type 2 Diabetes
Table 1
Clinical, laboratorial, and echocardiography characteristics of studied subjects.
| | Variable | Mean |
| | Age (years) | 68.97 ± 6.80 | | Gender | | | Male | 30.9% | | Female | 69.1% | | Diabetes duration (years) | 12.23 ± 8.34 | | BMI (kg/m2) | 27.95 ± 4.06 | | Waist circumference (cm) | 98.45 ± 12.43 | | Hip circumference (cm) | 101.71 ± 9.85 | | Fasting glucose (mg/dL) | 143.20 ± 56.41 | | HbA1C (%) | 7.90 ± 1.71 | | MDRD (mL/min/1.73 m2) | 91.85 ± 25.98 | | HDL (mg/dL) | 52.91 ± 22.73 | | LDL (mg/dL) | 97.95 ± 31.95 | | Triglycerides (mg/dL) | 136.61 ± 58.75 |
| | Medications | % |
| | Statin | 60.8 | | ACE inhibitor | 49.5 | | ARB | 23.7 | | CCB | 19.6 | | Aspirin | 52.6 | | Metformin | 76.3 | | Sulfonylurea | 32 | | Insulin | 34 |
| | Comorbidities | |
| | Hypertension | 79.4 | | Stroke | 4.1 | | Myocardial infarction | 3.1 | | CABG | 2.1 | | PVD | 1 | | Left atrial volume index (mL/m2) | 121.77 ± 22.81 | | Left ventricular mass index (g/m2) | 31.60 ± 7.64 | Orthostatic hypotension
(DSBP 20 and/or DDBP 10 mmHg) | 3.1% | Orthostatic hypertension
(DSBP 10 mmHg) | 20.6% |
|
|
ACE: angiotensin converting enzyme.
ARB: angiotensin II receptor blockers.
CCB: calcium channel blockers.
CABG: coronary artery bypass grafting.
PVD: peripheral vascular disease.
BMI: body mass index.
DSBP: differential systolic blood pressure.
DDBP: Differential diastolic blood pressure.
|
